• Allium Group (Caesarea, Israel) reported the nomination of the former director general of Hadassah Medical Organization, Shmuel Penchas, PhD, as a member of its board of directors. Allium makes next-generation stents geared toward minimally invasive treatments for malignant and benign obstructions in the urinary and gastro-intestinal tracts.

• Skip Goode was named president/CEO of Pathfinder (Nashville, Tennessee). Previously, he was head of sales for Medtronic Surgical Navigation. Pathfinder Therapeutics focuses on increasing the number and effectiveness of surgeries on abdominal organs or other organs below the chest.